Profil
Rui Yin Chu currently works at Duality Biotherapeutics, Inc., as Vice President-Translational Medicine from 2023.
Dr. Chu also formerly worked at Sanofi, as Associate Director and Cogent Biosciences, Inc., as Senior Director-Translational Medicine.
Dr. Chu received his graduate degree in 1986 and doctorate degree in 1990 from Chinese Academy of Agricultural Sciences.
Aktive Positionen von Rui Yin Chu
| Unternehmen | Position | Beginn |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 24.07.2023 |
Ehemalige bekannte Positionen von Rui Yin Chu
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Rui Yin Chu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Chinese Academy of Agricultural Sciences
Chinese Academy of Agricultural Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
















